Group 1 - Rosen Law Firm is investigating potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR) [1] - Investors who own shares of Danaher stock are encouraged to visit the firm's website for more information [1] Group 2 - Rosen Law Firm has a strong track record in securities class actions and shareholder derivative litigation, having achieved the largest securities class action settlement against a Chinese company at the time [2] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [2] - In 2019, Rosen Law Firm secured over $438 million for investors [2]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the upcoming lead plaintiff deadline on October 10, 2025, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased SelectQuote securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]. Group 2: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote rather than providing unbiased comparisons [4]. - It is claimed that SelectQuote received illegal kickbacks to steer Medicare beneficiaries to certain insurers, which resulted in non-compliance with applicable laws and regulations [4]. - The lawsuit asserts that the misleading statements about SelectQuote's business operations led to investor damages when the true details became public [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Centene Corporation securities between December 12, 2024, and June 30, 2025, of the September 8, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Centene securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by September 8, 2025, to serve as lead plaintiff [2]. - The lawsuit alleges that Centene's management provided misleading information regarding the company's revenue guidance and earnings per share for the 2025 fiscal year, while concealing adverse facts about enrollment and morbidity rates [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [3]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements since 2013 [3].

Core Viewpoint - Rosen Law Firm is investigating allegations against Disney for violating the COPPA by collecting personal data from children under 13 watching Disney videos on YouTube without parental consent [1][3]. Group 1: Allegations and Legal Actions - The Department of Justice (DOJ) has alleged that Disney Worldwide Services, Inc. and Disney Entertainment Operations LLC failed to properly label some YouTube videos as "Made for Kids," which allowed them to collect data and serve targeted ads to viewers under 13 [3]. - Disney is accused of continuing illegal data-collection practices even after being made aware of the issue, improperly serving targeted ads based on unlawfully collected data [3]. Group 2: Class Action Information - Parents of children under 13 who viewed Disney videos on YouTube may be entitled to compensation through a class action lawsuit without any out-of-pocket fees, facilitated by a contingency fee arrangement [2]. - Interested parties can join the prospective class action by contacting Phillip Kim, Esq. via a toll-free number or email [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone, and has consistently ranked in the top 4 for securities class action settlements since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PubMatic, Inc. securities during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from February 27, 2025, to August 11, 2025, and the lead plaintiff deadline is October 20, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3]. Group 3: Case Allegations - The lawsuit alleges that PubMatic made false and misleading statements regarding its business operations, particularly concerning a top demand side platform (DSP) buyer shifting clients to a new platform [4]. - This shift resulted in a reduction of ad spend and revenue for PubMatic, contradicting the positive statements made by the defendants [4]. - The lawsuit claims that when the true details were revealed, investors suffered damages due to the misleading information [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Tronox Holdings plc common stock during the specified Class Period, indicating potential legal issues surrounding the company's financial disclosures and performance [1][5]. Group 1: Lawsuit Details - The class action lawsuit is filed for purchasers of Tronox common stock between February 12, 2025, and July 30, 2025, inclusive [1]. - The lawsuit claims that Tronox provided misleading statements regarding its ability to forecast demand for its products, leading to a decline in sales and increased costs, which ultimately affected revenue projections [5]. Group 2: Investor Information - Investors who purchased Tronox common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. due to allegations of materially misleading business information issued to the investing public [1]. Group 1: Company Overview - Soleno Therapeutics, Inc. is facing scrutiny following a short report from Scorpion Capital that raised concerns about its recently approved treatment for Prader-Willi syndrome, VYKAT XR [4]. - The stock price of Soleno Therapeutics fell by 7.4% on August 15, 2025, and further declined by 4.9% on the subsequent trading day [4]. Group 2: Legal Actions - Rosen Law Firm is preparing a class action lawsuit seeking recovery of investor losses for those who purchased Soleno Therapeutics securities, with no out-of-pocket fees or costs for participants [2]. - Investors interested in joining the class action can submit their information through the Rosen Law Firm's website or contact them directly [3]. Group 3: Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field, including being ranked No. 1 by ISS Securities Class Action Services in 2017 [5]. - The firm has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Spectrum Pharmaceuticals, Inc. during the specified class period of the upcoming lead plaintiff deadline on September 24, 2025, as the lead plaintiff process has been reopened by the Court [1]. Group 1: Class Action Details - Investors who bought Spectrum Pharmaceuticals common stock between May 12, 2022, and September 22, 2022, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed against Spectrum Pharmaceuticals, and interested parties can join by contacting the law firm [3][5]. - The lawsuit alleges that Spectrum made false or misleading statements regarding its PINNACLE Study, which involved the drug poziotinib for lung cancer treatment, leading to investor damages when the truth was revealed [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including a notable settlement against a Chinese company and has recovered hundreds of millions for investors over the years [4]. Group 3: Class Certification Status - No class has been certified yet, meaning investors are not represented by counsel unless they retain one, and they can choose to remain absent from the class at this stage [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased SelectQuote, Inc. securities between September 9, 2020, and May 1, 2025, of the upcoming lead plaintiff deadline on October 10, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought SelectQuote securities during the specified class period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2]. - The lead plaintiff will represent other class members in directing the litigation [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time and has been ranked highly for its number of settlements since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3]. Group 3: Allegations Against SelectQuote - The lawsuit alleges that SelectQuote made false and misleading statements and failed to disclose critical information regarding its business practices [4]. - Specific allegations include directing Medicare beneficiaries to insurers that compensated SelectQuote, not providing unbiased comparisons, receiving illegal kickbacks, and non-compliance with laws and regulations [4]. - The lawsuit claims that these actions led to misleading positive statements about SelectQuote's business, resulting in investor damages when the truth was revealed [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Novo Nordisk A/S securities between May 7, 2025, and July 28, 2025, of the September 30, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Novo Nordisk securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by September 30, 2025, to serve as lead plaintiff [2]. - The lawsuit alleges that Novo Nordisk provided misleading statements about its growth potential while concealing material adverse facts [4]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3].